ArticleTurkish journal of haematology : official journal of Turkish Society of Haematology2013

Dasatinib May Override F317L BCR-ABL Kinase Domain Mutation in Patients with Chronic Myeloid Leukemia.

Ahmet Emre Eşkazan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.